Gene · 2071
Papers2,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| XAB2 dynamics during DNA damage-dependent transcription inhibition. | Elife | 2022 | 35880862 | PubTator, text mining | PubMed |
| Epidemiological Evidence for Associations Between Genetic Variants and Osteosarcoma Susceptibility: A Meta-Analysis. | Front Oncol | 2022 | 35860595 | PubTator, text mining | PubMed |
| Activated or Impaired: An Overview of DNA Repair in Neurodegenerative Diseases. | Aging Dis | 2022 | 35855336 | PubTator, text mining | PubMed |
| Late Presentation of Xeroderma Pigmentosa With Squamous Cell Carcinoma in Septic Shock: Report of a Rare Case. | Cureus | 2022 | 35855222 | PubTator, text mining | PubMed |
| Polymerases and DNA Repair in Neurons: Implications in Neuronal Survival and Neurodegenerative Diseases. | Front Cell Neurosci | 2022 | 35846567 | PubTator, text mining | PubMed |
| Genetic Risk of Second Primary Cancer in Breast Cancer Survivors: The Multiethnic Cohort Study. | Cancer Res | 2022 | 35834270 | PubTator, text mining | PubMed |
| Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non-Muscle-Invasive Bladder Cancer. | Clin Cancer Res | 2022 | 35833951 | PubTator, text mining | PubMed |
| Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery. | Nat Commun | 2022 | 35831314 | PubTator, text mining | PubMed |
| Pharmacologic Targeting of TFIIH Suppresses KRAS-Mutant Pancreatic Ductal Adenocarcinoma and Synergizes with TRAIL. | Cancer Res | 2022 | 35819261 | PubTator, text mining | PubMed |
| Can Cisplatin Therapy Be Improved? Pathways That Can Be Targeted. | Int J Mol Sci | 2022 | 35806243 | PubTator, text mining | PubMed |
| A stable XPG protein is required for proper ribosome biogenesis: Insights on the phenotype of combinate Xeroderma Pigmentosum/Cockayne Syndrome patients. | PLoS One | 2022 | 35802638 | PubTator, text mining | PubMed |
| G4-quadruplex-binding proteins: review and insights into selectivity. | Biophys Rev | 2022 | 35791380 | PubTator, text mining | PubMed |
| Revisiting chemoresistance in ovarian cancer: Mechanism, biomarkers, and precision medicine. | Genes Dis | 2022 | 35782973 | PubTator, text mining | PubMed |
| Correlation of changes in subclonal architecture with progression in the MMRF CoMMpass study. | Transl Oncol | 2022 | 35777247 | PubTator, text mining | PubMed |
| Analysis of Omics Data Reveals Nucleotide Excision Repair-Related Genes Signature in Highly-Grade Serous Ovarian Cancer to Predict Prognosis. | Front Cell Dev Biol | 2022 | 35769257 | PubTator, text mining | PubMed |
| An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy. | ESMO Open | 2022 | 35759853 | PubTator, text mining | PubMed |
| Super-Enhancers, Phase-Separated Condensates, and 3D Genome Organization in Cancer. | Cancers (Basel) | 2022 | 35740532 | PubTator, text mining | PubMed |
| Genomic analysis of Rad26 and Rad1-Rad10 reveals differences in their dependence on Mediator and RNA polymerase II. | Genome Res | 2022 | 35738899 | PubTator, text mining | PubMed |
| Insights into the structural dynamics and helicase-catalyzed unfolding of plant RNA G-quadruplexes. | J Biol Chem | 2022 | 35738400 | PubTator, text mining | PubMed |
| Metabolic Profiling of Bladder Cancer Patients' Serum Reveals Their Sensitivity to Neoadjuvant Chemotherapy. | Metabolites | 2022 | 35736490 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2071/papers?page=19